# Imperial College London: Observational study in Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting (2000 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Imperial College London |
| Sponsor type | Academic and hospital |
| Study | REAL-MS: Observational Database Study of AHSCT and MS Therapies |
| NCT ID | NCT07899502 |
| Phase | Observational |
| Status | recruiting |
| Conditions | Multiple Sclerosis; Multiple Sclerosis (MS) - Relapsing-remitting; Multiple Sclerosis (MS) Primary Progressive |
| Intervention types | procedure, drug |
| Target enrollment | 2000 |
| Site countries | United Kingdom |
| Posted | 2026-10-27 |
| Planned start | 2026-10-07 |
| Event | Newly registered study |
| Event date | 2026-10-27 |

## Why this score
- Posted in the last two weeks.
- 2000 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07899502). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.